Skip to main content

Immunotherapy After Bladder Cancer Surgery Shows Excellent Cancer-free Survival Rates

title

Immunotherapy after surgery helped reduce cancer recurrence in patients with urothelial cancer of the bladder or other sites in the urinary tract that had invaded the muscle and therefore posed a high risk for recurrence, according to clinical trial results presented at the American Urological Association (AUA) annual meeting in May.

Learn More

Referring a patient is easy. Just click the “Refer a Patient Online” button.